Ignite Creation Date:
2024-05-06 @ 8:18 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06333262
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-03-20
Brief Title:
Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia
Sponsor:
Organization:
Dana-Farber Cancer Institute